SC-58125 is primarily recognized for its role as a selective cyclooxygenase-2 (COX-2) inhibitor. It has been extensively used in research to study the effects of COX-2 inhibition in various biological processes. Its applications include investigating inflammation pathways, as COX-2 is a key enzyme involved in the production of pro-inflammatory mediators. SC-58125 has also been utilized in studies focused on understanding its potential therapeutic effects in conditions like arthritis, pain management, and certain types of cancer, where COX-2 overexpression is implicated. Additionally, it serves as a valuable tool in pharmacological studies to differentiate the roles of COX-1 and COX-2 in physiological and pathological states.